Methoxyflurane pain relief for awake hysteroscopy.

Phase 4

• Conditions: abnormal uterine bleeding; Anaesthesiology - Pain management; pain relief; Reproductive Health and Childbirth - Menstruation and menopause

• Registration Number: ACTRN12620000216910
• Lead Sponsor: Waikato DHB

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-24
• Last Update Posted: 3 March 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Patients booked to our hysteroscopy clinic, these patients have already been assessed from gynaecology clinic as suitable candidates for awake/outpatient hysteroscopies. They will be invited to participate in the trial on the day of their hysteroscopy.

Exclusion Criteria

Non-fluent English, known renal disease (Creatinine greater than or equal to 1.5 times the upper limit of normal), known liver disease (bilirubin greater than or equal to 2.5 times the upper limit of normal), known sensitivity to fluorinated anaesthetic, known cardiovascular disease, altered consciousness, personal history of malignant hyperthermia, family history of malignant hyperthermia unless personally tested to be negative,

Study & Design

• Study Type: Interventional
• Study Design: Not specified